observational epidemiological study of patients affected by systemic amyloidosis
patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene
minimum age of 18 years at the time of diagnosis
obtaining informed consent
nothing
The study population includes all adult patients referred to the participating centers with a diagnosis of amyloidosis or carriers of pathogenic mutations starting from 01/01/1981 diagnosed in accordance with current international guidelines.
Cohort
Other
Not listed
prevalence of amyloidosis
prevalence of amyloidosis in patients admitted to the UOs participating in the study
incidence of amyloidosis
incidence of amyloidosis in patients admitted to the UOs participating in the study
Observational epidemiological study of patients with systemic amyloidosis
characteristics of each etiology in terms of baseline clinical data
Types of cardiac clinical phenotype
Cardiac clinical phenotype in patients who at baseline are asymptomatic carriers of pathogenic mutations
Click on the lead sponsor to view all of their trials.
